drugset / Trial / NCT02957643

Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

NCT02957643

Phase 1/2 Completed 50 enrolled Hippocration General Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Timeline

Start
2016-11
Primary completion
2017-09
Completion
2017-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Iron Sulfate Small molecule Oral

Indications